Peptide Synthesis Market: Growth, Size, Share, and Trends

Report Code BT 6462
Published in Feb, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029

Overview

The global peptide synthesis market, valued at US$0.78 billion in 2023, is forecasted to grow at a robust CAGR of 8.7%, reaching US$0.81 billion in 2024 and an impressive US$1.41 billion by 2029. The peptide synthesis market is driven by the growing demand for therapeutic peptides in treating chronic diseases, including cancer, diabetes, and cardiovascular disorders. Advancements in solid-phase peptide synthesis (SPPS) and hybrid approaches have significantly improved efficiency, yield, and cost-effectiveness, fueling adoption in pharmaceutical R&D. The rise of personalized medicine has further expanded the need for custom peptide synthesis, supporting applications in targeted therapies and biomarker research. Emerging trends such as the integration of automation and AI-driven platforms among the instruments is further likely to fuel the market growth in coming years.

Peptide Synthesis Market – Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Peptide Synthesis Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and rising demand for peptide-based therapeutics

Expanding number of local pharmaceutical companies and growing emphasis on personalized and precision medicine in APAC is s accelerating the demand for custom peptides.

The development of peptide-based vaccine and incorporating non-natural amino acids to enhance the therapeutic properties of peptides is driving market growth

The Asia Pacific Peptide Synthesis market is expected to grow at a CAGR of 12.4% during the forecast period.

The high-cost instruments and regulatory challenges are likely to impact negatively on market growth

Global Peptide Synthesis Market Dynamics

DRIVER: Advancements in Peptide Therapeutics

Advancements in peptide therapeutics is one of the key driver for the growth of the peptide synthesis market. Peptides have emerged as a transformative class of therapeutics due to their ability to target specific disease pathways with high precision, offering a therapeutic advantage over traditional small molecules. Their increasing use in the treatment of complex diseases, such as cancer, metabolic disorders, and autoimmune conditions, has significantly fueled demand for peptide-based drugs. The growing recognition of peptides' unique properties—such as their enhanced specificity, reduced toxicity, and favorable pharmacokinetic profiles—has contributed to the rapid expansion of peptide therapeutics. For instance, peptide-based drugs such as Ozempic (semaglutide) and Trulicity (dulaglutide) have revolutionized diabetes management with their efficacy and prolonged action, becoming blockbuster therapies.

With the rising adoption of peptide therapeutics across multiple therapeutic areas, the demand for advanced peptide synthesis solutions continues to escalate. As the peptide therapeutics landscape evolves, the market for peptide synthesis is poised for sustained growth, driven by ongoing technological innovations that support the production of highly specialized and effective peptide-based treatments

RESTRAINT: High Cost of Peptide Synthesis and Instruments

The high cost of peptide synthesis and associated instruments is a significant factor restraining the growth of the peptide synthesis market. Producing high-purity peptides, particularly those with complex sequences or modifications, requires advanced technologies and reagents, driving up manufacturing expenses. These costs are further compounded by the need for specialized expertise and stringent quality control measures, making peptide synthesis a resource-intensive process. Additionally, the complexity of these instruments often necessitates skilled operators and ongoing technical support, further increasing operational costs. This financial barrier delays technology adoption and limits the ability of smaller players to compete in the peptide synthesis market

 

OPPORTUNITY: Adoption of personalized medicine

The growing adoption of personalized medicine is creating significant growth opportunities for the peptide synthesis market. Personalized medicine focuses on tailoring treatments to individual patient profiles based on genetic, environmental, and lifestyle factors. Peptides, with their high specificity, adaptability, and minimal side effects, are ideally suited to this approach, driving demand for advanced peptide synthesis technologies. One key area where personalized medicine is fostering growth is custom peptide synthesis. These peptides are designed to match the unique needs of a patient or a specific therapeutic target. For instance, neoantigen-based cancer immunotherapies, which use patient-specific tumor antigens to develop customized treatments, heavily rely on high-precision peptide synthesis. Companies like BioNTech and Moderna are leveraging personalized peptides in cancer vaccines and other therapies, significantly boosting the demand for custom synthesis services.

CHALLENGES: Environmental Concerns

Environmental concerns present a significant challenge in the peptide synthesis market, particularly as sustainability becomes a growing priority across industries. The synthesis of peptides often involves the use of hazardous chemicals, large volumes of organic solvents, and energy-intensive processes. These factors contribute to environmental degradation and raise concerns about the ecological impact of peptide production.

Solid-phase peptide synthesis (SPPS), a widely used method in the industry, generates substantial chemical waste, including solvents such as dimethylformamide (DMF) and dichloromethane (DCM), which are not only harmful to the environment but also subject to stringent disposal regulations. Improper handling of these materials can lead to soil and water contamination, creating additional regulatory and reputational risks for manufacturers.

Global Peptide Synthesis Market Ecosystem Analysis

The peptide synthesis market operates within an ecosystem comprising of a wide range of stakeholders playing a vital role in designing and adopting peptide synthesis. This ecosystem comprises of peptide synthesis products/services, regulatory bodies, and end users. The key market players include companies operating in the peptide synthesis market for several years with extensive product portfolios, vigorous global sales, and marketing networks.

Peptide Synthesis Market Ecosystem
 

The products segment dominated the peptide synthesis market in 2023.

Based on offerings, the market is segmented into products and services. By-products market is further divided into consumables and instruments. Among these consumables dominated the peptide synthesis market. The consumables segment is further bifurcated into reagents and other consumables. The reagents market is further divided into resins, amino acids, coupling reagents, dyes & fluorescent labeling reagents, deprotection agents, cleavage reagents, and other reagents. The demand for advanced resins has surged due to increased investment in pharmaceutical R&D and large-scale peptide-based therapeutics production. Furthermore, innovations in resin technologies, such as preloaded resins and specialized linkers, have a positive impact on peptide synthesis, enabling the production of complex peptides. For instance, polystyrene-based resins for traditional SPPS and PEG-based resins for improved solubility and versatility.

Peptide synthesizers dominated the instrument segment in 2023

The instruments segment is divided into peptide synthesizers, chromatography equipment, lyophilizers, and others. The peptide synthesizers segment dominated the segment and is anticipated to grow at a significant CAGR during the forecast period of 2024-2029. The key factors driving include technological advancements, such as enhanced automation, real-time monitoring, and the integration of AI for process optimization. Furthermore, the launch of technologically advanced products is likely to further impact positively on the market growth. For instance, Activotec Ltd launched of its Activo-Darwin Semi-Automated Peptide Synthesizer, designed for the synthesis of very high quality peptides in May 2024.

Peptide Synthesis services dominated the market

The services segment is divided into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. The peptide synthesis segment dominated the market in 2023. The segment dominates the market due to the increasing demand for custom and complex peptides across drug discovery, therapeutics, and research. Furthermore, key players offering specialized services such as modifications, and large-scale production at affordable cost is further likely to boost the segmental growth. Library peptide synthesis services are a specialized segment within the peptide synthesis market these are essential for drug discovery, biomarker identification, and therapeutic development.

The chemical technique segment is likely to grow at a faster pace during the forecast period.

Based on technique, the peptide synthesis market is segmented into chemical and biological. The chemical segment is further divided into solid-phase peptide synthesis, solution-phase peptide synthesis, and others. The biological segment is divided into recombinant DNA technology and enzymes. The chemical segment dominated the market in 2023. Solid-phase peptide synthesis (SPPS), dominated the peptide synthesis market due to the efficiency, scalability, and capability to produce high-purity peptides. Recombinant DNA (rDNA) technology plays a significant role in peptide synthesis, specifically in the production of complex peptides and proteins which are difficult to achieve through traditional chemical methods. rDNA-based peptide synthesis is advantageous for producing large-scale quantities of peptides and proteins with natural or post-translational modifications, which are essential for therapeutic applications.

Cancer segment is likely to grow at a faster pace during the forecast period.

Based on application, the market is divided into therapeutics, diagnostics, and research & development. Therapeutics by indication is further divided into cancer, diabetes, obesity, autoimmune disease, and other disease indications. Therapeutics by molecules is further segmented into peptide-based vaccines, peptide-drug conjugates (PDCs), peptide inhibitors, and other molecules. Therapeutic applications dominated the peptide synthesis market, driven by the growing demand for peptide-based drugs in various applications. Among these, the cancer segment is expanding at an accelerated pace due to the increasing prevalence of cancer and the rising adoption of peptide-based therapies, including targeted treatments, vaccines, and immunotherapies.

Pharmaceutical and biotechnology companies dominated the end user segment.

The peptide synthesis market is segmented by end users into pharmaceutical and biotechnology companies, CDMOS & CROS, academic and research institutes, medical device companies, and hospitals and diagnostic centers. The pharmaceutical and biotechnology companies segment held the largest market share in 2023. Pharmaceutical and biotechnology companies dominated segment, primarily driven by investment in targeted therapies, and peptide-based drugs. CROs & CDMOs segment is further likely to grow at a significant CAGR owing to increased outsourcing of peptide synthesis and collaboration with biopharma companies for production of peptid-based products. Additionally, expansion in the manufacturing capcities is further likely to boost the market growth. For instance, in January 2025, BioDuro, a Contract Research, Development, and Manufacturing Organization (CRDMO) opened a of a fully automated solid-phase peptide synthesis scale-up laboratory at Shanghai Zhangjiang High-tech Park campus in China.

US dominated North America Peptide Synthesis Market 2023.

The peptide synthesis market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the global peptide synthesis market and is expected to maintain a leading market share during the forecast period. The US dominated the North American peptide synthesis market owing to the presence of leading biopharmaceutical companies and CROs & CDMOs. Furthermore, high investment in research and development in the country is likely to fuel the market growth. For instance, in September 2024, Cambrex a global contract development and manufacturing organization (CDMO) based in US developed a new liquid-phase peptide synthesis (LPPS) technology, new LPPS technology significantly reduces solvent use and reagent excess compared to traditional solid-phase peptide synthesis. The Asia Pacific region is anticipated to grow at a significant CAGR owing increased pharmaceutical and biotechnology investments, a large patient population, and expanding research capabilities.

HIGHEST CAGR MARKET IN 2023
CHINA FASTEST GROWING MARKET IN THE REGION
Peptide Synthesis Market Region

Recent Developments of Peptide Synthesis Market

  • In May 2024, Vapourtec launched compact and flexible Peptide-ExplorerLT peptide synthesizer.
  • In May 2024, Activotec Ltd launched Activo-Darwin Semi-Automated Peptide Synthesizer a instrument designed for the synthesis of very high quality peptides.

Key Market Players

Want to explore hidden markets that can drive new revenue in Peptide Synthesis Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered Offerings, Products, Consumables, Instruments, Services, Applications, Technique and End User
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

 

Key Questions Addressed by the Report

Who are the key players in the peptide synthesis market?
Key players in the peptide synthesis market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), Agilent Technologies Inc. (US), GenScript (China), and Bachem Holding AG (Switzerland), among others.
Which instrument segment dominates the peptide synthesis market?
The peptide synthesizers segment dominated the market in 2023.
Which application segment of the peptide synthesis market is expected to register the highest growth?
The therapeutics application segment is anticipated to register the highest CAGR during the forecast period.
What is the market size for the peptide synthesis market?
The global peptide synthesis market is anticipated to reach USD 1.41 billion in 2029 from USD 0.81 billion in 2024.
At what rate the peptide synthesis market is growing?
The global peptide synthesis market is expected to grow at a significant CAGR of 11.7%

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Peptide Synthesis Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
15
EXECUTIVE SUMMARY
54
PREMIUM INSIGHTS
71
MARKET OVERVIEW
89
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    OPPORTUNITIES
    CHALLENGES
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022-2024
    AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022-2024
  • 5.5 SUPPLY CHAIN ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
    - LIQUID-PHASE PEPTIDE SYNTHESIS
    - ENZYMATIC SYNTHESIS
    - CONTINUOUS FLOW SYNTHESIS
    COMPLEMENTARY TECHNOLOGIES
    - PURIFICATION TECHNIQUES
    - LABELING AND TRACKING TECHNOLOGIES
    ADJACENT TECHNOLOGIES
    - CELL-FREE PROTEIN SYNTHESIS
    - PROTEIN DESIGN AND ENGINEERING
  • 5.9 PATENT ANALYSIS
  • 5.10 KEY CONFERENCES & EVENTS IN 2025-2026
  • 5.11 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.12 INVESTMENT AND FUNDING SCENARIO
  • 5.13 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITION RIVALRY
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA FOR END USERS
  • 5.15 TRADE ANALYSIS
    IMPORT VALUE, 2019-2023
    EXPORT VALUE, 2019-2023
    IMPORT VOLUME, 2019-2023
    EXPORT VOLUME, 2019-2023
  • 5.16 IMPACT OF GENERATIVE AI/AI ON THE PEPTIDE SYNTHESIS MARKET
PEPTIDE SYNTHESIS MARKET, BY OFFERING (VALUE (USD MILLION) -2022, 2029)
112
  • 6.1 INTRODUCTION
  • 6.2 PRODUCTS
  • 6.3 SERVICES
PEPTIDE SYNTHESIS MARKET, BY PRODUCTS, 2022-2029 (VALUE (USD MILLION) -2022, 2029)
134
  • 7.1 INTRODUCTION
  • 7.2 CONSUMABLES
    REAGENTS
    - RESINS
    - AMINO ACIDS
    - COUPLING REAGENTS
    - DYES & FLUORESCENT LABELING REAGENTS
    - DEPROTECTION REAGENTS
    - CLEAVAGE REAGENTS
    - OTHER REAGENTS
    OTHER CONSUMABLES
  • 7.3 INSTRUMENTS
    PEPTIDE SYNTHESIZER
    - AUTOMATED PEPTIDE SYNTHESIZERS
    - MANUAL PEPTIDE SYNTHESIZERS
    CHROMATOGRAPHY SYSTEMS
    LYOPHILIZERS
    OTHER INSTRUMENTS
PEPTIDE SYNTHESIS MARKET, BY SERVICES, 2022-2029 (VALUE (USD MILLION) -2022, 2029)
145
  • 8.1 INTRODUCTION
  • 8.2 PEPTIDE LIBRARY SYNTHESIS
  • 8.3 PEPTIDE SYNTHESIS
  • 8.4 PEPTIDE PURIFICATION SERVICES
  • 8.5 PEPTIDE ANALYSIS SERVICES
PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE, 2022-2029 (VALUE (USD MILLION) -2022, 2029)
192
  • 9.1 INTRODUCTION
  • 9.2 CHEMICAL METHOD
    SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
    LIQUID-PHASE PEPTIDE SYNTHESIS (LPPS)
    OTHER CHEMICAL METHODS
  • 9.3 BIOLOGICAL METHOD
    RECOMBINANT DNA TECHNOLOGY
    ENZYMATIC SYNTHESIS
PEPTIDE SYNTHESIS MARKET, BY APPLICATION, 2022-2029 (VALUE (USD MILLION) -2022, 2029)
219
  • 10.1 INTRODUCTION
  • 10.2 THERAPEUTICS
    THERAPEUTICS BY INDICATIONS
    - CANCER
    - DIABETES
    - OBESITY
    - AUTOIMMUNE DISEASES
    - OTHER DISEASE INDICATIONS
    THERAPEUTICS BY MOLECULE
    - PEPTIDE-BASED VACCINES
    - PEPTIDE-DRUG CONJUGATES (PDCS)
    - PEPTIDE INHIBITORS
    - OTHER MOLECULES
    - OTHERS
  • 10.3 DIAGNOSTICS
  • 10.4 DISCOVERY AND DEVELOPMENT
PEPTIDE SYNTHESIS MARKET, BY END USER (PRODUCT), 2022-2029 (VALUE (USD MILLION) -2022, 2029)
234
  • 11.1 INTRODUCTION
  • 11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
  • 11.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
  • 11.4 ACADEMIC & RESEARCH INSTITUTES
  • 11.5 MEDICAL DEVICE COMPANIES
  • 11.6 HOSPITALS AND DIAGNOSTIC CENTERS
PEPTIDE SYNTHESIS MARKET, BY END USER (SERVICES), 2022-2029 (VALUE (USD MILLION) -2022, 2029)
244
  • 12.1 INTRODUCTION
  • 12.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
  • 12.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CONTRACT MANUFACTURING ORGANIZATIONS (CMOS)
  • 12.4 ACADEMIC & RESEARCH INSTITUTES
  • 12.5 MEDICAL DEVICE COMPANIES
  • 12.6 HOSPITALS AND DIAGNOSTIC CENTERS
PEPTIDE SYNTHESIS MARKET, BY REGION, 2022-2029 (VALUE (USD MILLION) -2022, 2029)
251
  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    NORTH AMERICA: MACROECONOMIC OUTLOOK
    US
    CANADA
  • 13.3 EUROPE
    EUROPE: MACROECONOMIC OUTLOOK
    GERMANY
    UK
    FRANCE
    ITALY
    SPAIN
    REST OF EUROPE
  • 13.4 ASIA PACIFIC
    ASIA PACIFIC: MACROECONOMIC OUTLOOK
    JAPAN
    CHINA
    INDIA
    SOUTH KOREA
    AUSTRALIA
    REST OF ASIA PACIFIC
  • 13.5 LATIN AMERICA
    LATIN AMERICA: MACROECONOMIC OUTLOOK
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 13.6 MIDDLE EAST
    MIDDLE EAST: MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - UNITED ARAB EMIRATES (UAE)
    - SAUDI ARABIA (KSA)
    - REST OF GCC COUNTRIES
    REST OF MIDDLE EAST
  • 13.7 AFRICA
    AFRICA: MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
260
  • 14.1 OVERVIEW
  • 14.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
  • 14.3 REVENUE ANALYSIS, 2019-2023
  • 14.4 MARKET SHARE ANALYSIS, 2023
  • 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - COMPANY FOOTPRINT
    - REGION FOOTPRINT
    - PRODUCT FOOTPRINT
    - SERVICE FOOTPRINT
    - END USER FOOTPRINT
  • 14.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - DETAILED LIST OF KEY STARTUPS/SMES
    - COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 14.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 14.8 BRAND/PRODUCT COMPARISON
  • 14.9 COMPETITIVE SCENARIO AND TRENDS
    PRODUCT LAUNCHES
    DEALS
    OTHER DEVELOPMENTS
COMPANY PROFILES
310
  • 15.1 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    GENSCRIPT
    ANASPEC
    MERCK KGAA
    BACHEM
    AGILENT TECHNOLOGIES, INC.
    MESA LABS, INC.
    SYNGENE INTERNATIONAL LIMITED
    BIOTAGE AB
    CEM CORPORATION
    DALTON PHARMA SERVICES
    CSBIO
    BIO-SYNTHESIS INC
    PROTEOGENIX
    INVIVOGEN AB
    BIOSYNTH
  • 15.2 OTHER PLAYERS
    AURIGENE PHARMACEUTICAL SERVICES LTD.
    CORDENPHARMA
    JPT PEPTIDE TECHNOLOGIES
    PUROLITE
    BIOMATIK
    CPC SCIENTIFIC INC.
    ADVANCED CHEMTECH
    AMBIOPHARM INC.
    LUXEMBOURG BIO TECHNOLOGIES
    AAPPTEC
    ANYGEN
    CHEMPEP
APPENDIX
350
  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 16.3 AVAILABLE CUSTOMIZATIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

The research study involved the wide use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global peptide synthesis market. Widespread interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size is estimated through secondary research (top-down and bottom-up) followed by data triangulation with inputs from industry experts to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the technical, market-oriented, and commercial study of the peptide synthesis market. The secondary sources used for this study include World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), National Institutes of Health (NIH), Health Canada, Indian Pharmaceutical Association (IPA), the Pharmaceutical Research and Manufacturers of America (PhRMA), the Association of Biomolecular Resource Facilities, Journal of the American Chemical Society, American Peptide Society, Australian Peptide Association, European Peptide Society, Indian Peptide Society, Protein Science Society of Japan (PSSJ), American Peptide Society (APS), Pharmaceutical Research and Manufacturers of America (PhRMA), and the World Journal of Pharmaceutical Sciences, Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations among others. These secondary sources were also used to obtain major information about key market players, and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analysed to arrive at the market size of the global peptide synthesis market, which was further validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global peptide synthesis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biopharmaceutical industries, CROS & CDMOs and among others from the supply side, such as C-level and D-level executives, product/service managers, marketing & sales managers of key manufacturers, distributors, and channel partners. The primary interviews were conducted across six major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Approximately 65% and 35% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Peptide Synthesis Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the peptide synthesis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Peptide Synthesis Market

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Peptide synthesis is the process of creating peptides, which are short chains of amino acids linked by peptide bonds. These molecules are essential in biological systems and are widely used in research, diagnostics, and therapeutics. Peptide synthesis typically occurs through solid-phase synthesis (SPPS), liquid-phase synthesis, or hybrid approaches, enabling precise control over sequence and structure. SPPS, the most common method, involves anchoring the peptide to a solid resin, allowing stepwise addition of amino acids.

Stakeholders

  • Companies Providing Peptide Synthesis Services
  • Research Institutes and Academic Centers
  • Suppliers and Distributors of Peptide synthesis
  • Pharmaceutical and Biotechnology Companies
  • Business Research and Consulting Service Providers
  • Venture Capitalists
  • Contract Research Organizations and Contract Development Manufacturing Organizations
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the peptide synthesis market by value by offerings, products, consumables, services, application, technique, end user and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall peptide synthesis market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as product/service launches, partnerships, agreements, collaborations, and expansions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

 

Previous Versions of this Report

Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO) - Global Forecast to 2028

Report Code BT 6462
Published in Jul, 2023, By MarketsandMarkets™

Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026

Report Code BT 6462
Published in Jan, 2022, By MarketsandMarkets™

Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026

Report Code BT 6462
Published in Jul, 2018, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Peptide Synthesis Market

DMCA.com Protection Status